Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kesko Oyj - Managers' Transactions (Riikka Joukio)

Kesko Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Riikka JoukioPosition: Other senior manager Issuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95Notification type: INITIAL NOTIFICATIONReference number: 55573/5/4 ____________________________________________Transaction date: 2024-03-15Outside a trading venueInstrument type: SHAREISIN: FI0009000202Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE  Transaction details(1): Volume: 14281 Unit price: 0 EUR  Aggregated transactions (1)

Akobo Minerals AB (publ) – Notice of transaction by PDMR

Oslo, Norway – 15 March 2024 – Reference is made to the stock exchange announcement published by Akobo Minerals AB (publ) (the "Company") on 27 February 2024, in which the Company announced a subsequent rights issue (the "Subsequent Rights Issue") of up to 28,346,785 new shares in the Company (the "New Shares"), each with a quota value of SEK 0.0371599322777818, at a subscription price of NOK 1 per New Share (the ʺSubscription Priceʺ). In aggregate, 53,150,223 subscription rights (the "Subscription Rights") have been issued, whereby fifteen (15) Subscription Rights gives the right to

Kesko Oyj - Managers' Transactions (Sami Kiiski)

Kesko Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Sami KiiskiPosition: Other senior manager Issuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95Notification type: INITIAL NOTIFICATIONReference number: 55565/5/4 ____________________________________________Transaction date: 2024-03-15Outside a trading venueInstrument type: SHAREISIN: FI0009000202Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE  Transaction details(1): Volume: 2944 Unit price: 0 EUR  Aggregated transactions (1):

Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments

Copenhagen, Denmark, 15 March 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Firm commitments of exercise and guarantees from management and larger shareholders now cover 71% of the 28,542,348 outstanding warrants of series TO 3    · Soft exercise commitments cover an additional 6% · Less than halfway into the exercise period, coverage of warrants of series TO 3 already exceeds the outcome of 74% exercise and guarantor coverage of warrants of series TO 2 in October 2023Today, Brain+ A/S (“Brain+” or “the Company”) announced to have received additional commitments from

Kesko Oyj - Managers' Transactions (Ari Akseli)

Kesko Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Ari AkseliPosition: Other senior manager Issuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95Notification type: INITIAL NOTIFICATIONReference number: 55564/5/4 ____________________________________________Transaction date: 2024-03-15Outside a trading venueInstrument type: SHAREISIN: FI0009000202Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE  Transaction details(1): Volume: 7823 Unit price: 0 EUR  Aggregated transactions (1):

Annual General Meeting in BE Group AB

Notice is given to the shareholders of BE Group AB (publ), reg. no. 556578-4724 of the Annual General Meeting to be held on Thursday April 18, 2024, at 4 pm CET, at HighCourt, Malmöhusvägen 1, in Malmö. Right to attendA person who wishes to participate in the annual general meeting must: · be listed in the share register kept by Euroclear Sweden AB on Wednesday 10 April 2024, and · give notice of attendance at the meeting to the company no later than Friday 12 April 2024, preferably before 12.00 noon.  In order to be entitled to participate in the annual general meeting, a

Kesko Oyj - Managers' Transactions (Jorma Rauhala)

Kesko Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Jorma RauhalaPosition: Chief Executive Officer Issuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95Notification type: INITIAL NOTIFICATIONReference number: 55562/5/6 ____________________________________________Transaction date: 2024-03-15Outside a trading venueInstrument type: SHAREISIN: FI0009000202Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE  Transaction details(1): Volume: 9338 Unit price: 0 EUR  Aggregated transactions (

Axactor ASA: Mandatory Notification of Trade by Primary Insider

Oslo, 15 March 2024 Karl Todsen Mamelund (Chief Investment Officer in Axactor ASA), has on 14 March 2024 acquired 21,858 shares in the Company at an average price of 4.63 per share. After this transaction Karl Todsen Mamelund controls 196,858 shares in the Company. Please refer to the attached notifications of transactions for further details. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Change in the holding of Kesko Corporation's treasury shares

Kesko Corporation has today transferred a total of 91,716 of its own B shares (KESKOB) held by the Company as treasury shares to members of management and other selected key persons who were included in the target group for the PSP 2022-2025 share-based commitment and incentive plan in the 2022-2023 performance periods. In addition, Kesko has today transferred a total of 84,592 of its own B shares (KESKOB) held by the Company as treasury shares to members of commitment and incentive plan KPSP 2021,  132 of its own B shares (KESKOB) held by the Company as treasury shares to members of

HKScan's Annual and Responsibility Report 2023 published

HKScan Corporation, Stock Exchange Release, 15 March 2024 at 11:30 a.m. EETHKScan has published its Annual and Responsibility Report 2023 in English at https://www.hkscan.com/en/investors-information/annual-and-responsibility-report-2023/ and in Finnish at https://www.hkscan.com/fi/sijoittajat/vuosi-ja-vastuullisuusraportti-2023/. As part of its Annual and Responsibility Report, the company has also published the Report of the Board of Directors and Financial Statements, Corporate Governance Statement and Remuneration Report. The disclosure of non-financial information is included in the

Arctic Bioscience – Extension of share options to members of management group

The Board of Directors of Arctic Bioscience AS has resolved to extend the share option agreements for the following members of the management group: Yuming Feng (EVP Global Business Development), Daniele Mancinelli (CTO), Hogne Hallaråker (CSO) and Per Christian Sæbø (COO).The exercise prices in the agreement for Feng is maintained at NOK 27,90 per share and maintained at NOK 9,845 per share in the agreements for Mancinelli, Hallaråker and Sæbø. The duration of the option agreements is extended until 28. February 2025. All options being exercised into shares during the duration period

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 64 – 15 MARTS 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Notice of Annual General Meeting of Orexo

The shareholders in Orexo AB (publ), reg. no. 556500-0600, registered office Uppsala, are summoned to the annual general meeting, to be held on Friday 26 April 2024, at 16.00 pm in Orexo’s facilities at Rapsgatan 7E in Uppsala, Sweden.   Participation, etc.   Shareholders who wish to participate in the meeting must be recorded in the share register maintained by Euroclear Sweden AB on Thursday 18 April 2024, and notify Orexo of their intention to attend the meeting not later than on Monday 22 April 2024 by post to Orexo AB, P.O. Box 303, SE-751 05 Uppsala, Sweden, by telephone

Checkin.com Group has signed an agreement with leading North American AI platform

Checkin.com Group (STO:CHECK) has signed a cooperation agreement with a leading North American AI platform, part of a technology group publicly listed in the US. The group is a global leader in digital solutions across many industry verticals, including tech, communications, ecommerce, financial services, insurance and healthcare.Following a completed Proof of Concept period the Checkin.com software is already integrated on the AI platform, and is now available globally to the platform's community. The community includes many globally leading brands within industries such as Payments and

Akelius publishes annual report and sustainability report for 2023

Akelius Residential Property AB (publ) has today published its annual report and sustainability reportfor 2023.  The document is available on Akelius’ website at https://www.akelius.com/en/investor/reports  Berlin, 2024-03-15  Ralf Spann CEO +49 173 643 65 90 ralf.spann@akelius.de (ralf.spann@akelius.de%0b%0d)  This information is information that Akelius Residential Property AB (publ) is obliged to make public pursuant to the Securities Markets Act.The information was submitted for publication at 10.00am CET on 15 March 2024. Akelius Residential Property

The Board of AQ Group proposes that the Annual General Meeting 2024 decides on a share split 5:1

The Board of Directors of AQ Group AB has decided to propose that the Annual General Meeting 18 April 2024 resolves to divide each share into five shares (Share split 5:1) and thereby increase the number of shares five times. The purpose of the division of shares is to achieve an appropriate number of shares for the company. The complete proposal will be included in the notice to the Annual General Meeting 2024, which will be published this day. __________________________________________________________________________________________ For further information, please contact:

Pemamek launches PEMA Skycoil: Revolutionary induction preheater for offshore wind tower and foundation manufacturers

PEMA Skycoil sets a new milestone in the inductive preheating technology. Curve-shaped PEMA Skycoil offers high-precision heating performance for welding heavy tubular workpieces up to 15m (49ft) in diameter. Pemamek, a global leader in welding automation technology, has introduced the PEMA Skycoil, an induction preheater designed for offshore wind foundations and tower manufacturing. The new product is set to redefine the heating process in terms of energy efficiency, heating performance, and operational safety. Developed in collaboration with the global green tech company,

Fazer opens a shop in the Lappeenranta harbour

Fazer responds to the wishes of the city's residents by opening a shop in a historic building located in Lappeenranta harbour in early summer. The core of its selection will be locally made products, with other Fazer products included to complement the offering. With the opening of the shop, Fazer celebrates the anniversary of confectionery production in Lappeenranta and the 375-year history of the city of Lappeenranta.In early summer, Fazer will open a shop in the old pair of buildings in the fortress located in the Lappeenranta harbour at Satamatie 15-17. The shop has been designed in

Minesto publishes prospectus in connection with the rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA, BELARUS, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE. On 26 February 2024, Minesto AB (publ) ("Minesto" or the "Company") announced that the Board of Directors, conditional on the

NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Monday, April 22, 2024 at 3.00 p.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 2.00 p.m. CEST. A lighter snack will be served after the AGM. The Board of Directors of Getinge has decided to allow the shareholders to also attend the AGM by postal voting in accordance with the regulations in Getinge’s Articles of Association as further described below. Further information regarding

Proposal for election of board members in Nexam Chemcial Holding AB

The Nomination Committee proposes re-election of the Board members Cecilia Jinert Johansson, Lennart Holm, Magnus Wikström and Martin Roos as regular Board members. Jonna Opitz has declined re-election. Cecilia Jinert Johansson is proposed for election as Chairman of the Board.Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact: Cecilia Jinert Johansson, Chairman of the Board, +46-706 27 21 63, cecilia.jinert-johansson@nexamchemical.com

Lundbeck’s potential first-in-class therapy for migraine prevention enters advanced clinical stage

PROCEED, a clinical phase IIb dose-finding trial will assess the efficacy and safety of subcutaneously administered Lu AG09222 in migraine prevention.H. Lundbeck A/S (Lundbeck) announced the advancement of the clinical development of Lu AG09222 for migraine prevention with the initiation of PROCEED, a randomized, double-blind, phase IIb, dose-finding trial to assess efficacy and safety of multiple subcutaneously administered doses. The PROCEED trial builds on the positive results of the HOPE phase IIa Proof-of-Concept trial demonstrating efficacy of intravenously administered Lu AG09222

Notice to attend the Annual General Meeting 2024

The shareholders of SSAB AB (publ) (company reg. no. 556016-3429) are hereby given notice to the Annual General Meeting to be held on Wednesday, April 24, 2024 at 1 p.m. The Board of Directors has decided that shareholders may exercise their voting rights at the Annual General Meeting also by postal voting.Location Sergel Hub, Sveavägen 10a, Stockholm Admission and registration will commence at 12.00 a.m. Right to participate and notice of participation A) PARTICIPATION AT THE MEETING VENUE A person who wishes to attend the meeting venue in person or by proxy must · be

There are no items matching the current filter
There are no more items matching the current filter
Back to top